Show Notes
AI is rapidly reshaping life sciences manufacturing—but as intelligent systems move into regulated environments, questions around validation, governance, and trust become unavoidable.
In this episode of Augmented Ops, host Michelle Vuolo, Head of Quality at Tulip, is joined by Bryan Ennis, Chief Quality Officer and Founder of Sware, and Martin Heitmann, of the Triality Group. Together, they explore what it really takes to deploy AI responsibly in pharma, biotech, and medtech operations.
The conversation examines why many AI initiatives stall at the pilot stage, how validation practices must evolve for probabilistic systems, and where organizations are already seeing real value—from predictive maintenance to quality signal detection and validation automation. They also discuss emerging regulatory guidance, including Annex 22, and why regulators are not anti-AI—but deeply skeptical of black-box systems.
Throughout the discussion, a consistent theme emerges: successful AI adoption is less about the technology itself and more about process design, data quality, human oversight, and building evidence that systems are safe, transparent, and fit for purpose.
This episode offers a grounded, experience-driven perspective on how life sciences organizations can move from experimentation to scale—without compromising patient safety or compliance.
Watch the full episode on YouTube: https://youtu.be/7keK_4zDaTg
Augmented Ops is a podcast for industrial leaders, citizen developers, shop floor operators, and anyone else that cares about what the future of frontline operations will look like across industries. This show is presented by Tulip, the Frontline Operations Platform. You can find more from us at Tulip.co/podcast or by following the show on LinkedIn. Special Guests: Bryan Ennis and Martin Heitmann.
More from Augmented Ops
For decades, the United States bet that invention alone would keep it competitive. Twenty years ago, the US led in 60 of 64 key technologies. Today, China leads in 57 of them. The country no longer has an invention problem, it has an industrialization problem.
Three months into the agentic AI shift, manufacturing finds itself at the same inflection point a generation of CEOs faced at the dawn of digital: lean in now, or wait for someone else to prove it works. The cost of waiting just got steeper.
Geopolitical pressure is reshaping how the US buys and builds for defense. Nick Sinai of Insight Partners breaks down the shift from cost-plus to commercial procurement, the rise of venture-backed defense tech, and how to move fast without losing safety.
Manufacturing is entering a new phase of AI adoption, one where intelligent systems don’t just generate insights but take action in context. In this episode of Augmented Ops, host Mason Glidden, Tulip’s Chief Product Officer, is joined by Olga Stroilova, Group Product Lead, and Pete Hartnett, Group Product Manager, to discuss how agentic AI is redefining what’s possible on the factory floor.
What do a floating barge the size of four aircraft carriers, a Shell refinery, and the future of energy resilience have in common? They all depend on knowing, with precision, how much life is left in the steel.